Outcomes after resection of leiomyosarcomas of the inferior vena cava: A pooled data analysis of 377 cases. (March 2015)
- Record Type:
- Journal Article
- Title:
- Outcomes after resection of leiomyosarcomas of the inferior vena cava: A pooled data analysis of 377 cases. (March 2015)
- Main Title:
- Outcomes after resection of leiomyosarcomas of the inferior vena cava: A pooled data analysis of 377 cases
- Authors:
- Wachtel, Heather
Gupta, Meera
Bartlett, Edmund K.
Jackson, Benjamin M.
Kelz, Rachel R.
Karakousis, Giorgos C.
Fraker, Douglas L.
Roses, Robert E. - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="abs0010"> <title id="sectitle0010">Abstract</title> <sec> <title id="sectitle0015">Background</title> <p id="abspara0010">Primary leiomyosarcomas of the inferior vena cava (IVC) pose unique surgical challenges. Due to the rarity of the disease, little definitive data exists on prognosis and treatment options.</p> </sec> <sec> <title id="sectitle0020">Methods</title> <p id="abspara0015">A pooled data analysis was performed on all cases of initial IVC leiomyosarcoma resection identified by literature search (<italic>n</italic> = 371) and our institutional database (<italic>n</italic> = 6). Kaplan–Meier and Cox regression analyses were performed to identify factors associated with disease-free survival (DFS) and overall survival (OS).</p> </sec> <sec> <title id="sectitle0025">Results</title> <p id="abspara0020">Patients were predominantly female (76%, <italic>n</italic> = 286); the median age of presentation was 55 years. Five-year DFS and OS were 6% and 55%, respectively. Preoperative factors independently associated with decreased OS included older age (HR:1.05, 95% CI:1.00–1.09), larger tumor size (HR:1.14, 95% CI:1.04–1.24), resection of adjacent organ(s) (HR:3.62, 95% CI:1.34–9.77), and R2 resection (HR:7.80, 95% CI:1.94–32.05). Isolated involvement of the suprarenal infrahepatic IVC was associated with longer OS (HR:0.22, 95% CI:0.06–0.78). A scoring system incorporating independent predictors of OS stratified outcomes:<abstract xml:lang="en" abstract-type="author" id="abs0010"> <title id="sectitle0010">Abstract</title> <sec> <title id="sectitle0015">Background</title> <p id="abspara0010">Primary leiomyosarcomas of the inferior vena cava (IVC) pose unique surgical challenges. Due to the rarity of the disease, little definitive data exists on prognosis and treatment options.</p> </sec> <sec> <title id="sectitle0020">Methods</title> <p id="abspara0015">A pooled data analysis was performed on all cases of initial IVC leiomyosarcoma resection identified by literature search (<italic>n</italic> = 371) and our institutional database (<italic>n</italic> = 6). Kaplan–Meier and Cox regression analyses were performed to identify factors associated with disease-free survival (DFS) and overall survival (OS).</p> </sec> <sec> <title id="sectitle0025">Results</title> <p id="abspara0020">Patients were predominantly female (76%, <italic>n</italic> = 286); the median age of presentation was 55 years. Five-year DFS and OS were 6% and 55%, respectively. Preoperative factors independently associated with decreased OS included older age (HR:1.05, 95% CI:1.00–1.09), larger tumor size (HR:1.14, 95% CI:1.04–1.24), resection of adjacent organ(s) (HR:3.62, 95% CI:1.34–9.77), and R2 resection (HR:7.80, 95% CI:1.94–32.05). Isolated involvement of the suprarenal infrahepatic IVC was associated with longer OS (HR:0.22, 95% CI:0.06–0.78). A scoring system incorporating independent predictors of OS stratified outcomes: score 4–5 (<italic>n</italic> = 10, median OS 6 months), score 2–3 (<italic>n</italic> = 88, median OS 23 months) compared to a score of 0–1 (<italic>n</italic> = 44, median OS 29 months).</p> </sec> <sec> <title id="sectitle0030">Conclusions</title> <p id="abspara0025">Following resection of IVC leiomyosarcomas, recurrence is a near certainty; long-term survival, however is possible. The dominant predictors of survival include margin status, tumor size and radical resection. These can be combined into a risk score that has prognostic value.</p> </sec> </abstract> … (more)
- Is Part Of:
- Surgical oncology. Volume 24:Number 1(2015)
- Journal:
- Surgical oncology
- Issue:
- Volume 24:Number 1(2015)
- Issue Display:
- Volume 24, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 24
- Issue:
- 1
- Issue Sort Value:
- 2015-0024-0001-0000
- Page Start:
- 21
- Page End:
- 27
- Publication Date:
- 2015-03
- Subjects:
- Cancer -- Surgery -- Periodicals
Neoplasms -- surgery -- Periodicals
Cancer -- Chirurgie -- Périodiques
Electronic journals
616.994059 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09607404 ↗
http://www.so-online.net/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09607404 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09607404 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.suronc.2014.10.007 ↗
- Languages:
- English
- ISSNs:
- 0960-7404
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8548.242000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3336.xml